Health

Current Picks

Zambia's Cholera Vaccine Stockpile Runs Dry as Cases Climb

By Min Park / Oct 20, 2026

Zambia's cholera resurgence emptied a global vaccine stockpile. Experts disagree on whether reactive mass campaigns work as well as water and sanitation investment.

Asthma Care Follows the Coverage Formulary, Not the Spirometer

By Raphael Andriamanjato / Oct 20, 2026

How payer formularies and prior authorization shape asthma treatment more than spirometry, and what clinicians can do within those constraints.

Occupational Asthma Screening Lags in Vietnam's Garment Factories

By Min Park / Oct 20, 2026

Vietnam's garment factories expose workers to cotton and synthetic dusts that cause occupational asthma, yet routine screening and referral pathways remain absent.

India's Fatty Liver Cases Follow the Waistline, Not the Alcohol

By Elena Vargas / Oct 20, 2026

Fatty liver disease in India is increasingly driven by central obesity and insulin resistance, not alcohol. Kerala clinics show why waist measurement matters more than BMI.

Asthma Inhalers Cost the Same While Hospital Admissions Diverge by District

By Esther Okello / Oct 20, 2026

The same asthma inhaler costs the same everywhere, yet hospital admissions vary several-fold by district. The gap is clinical practice, not drug price.

Urban Indians Develop Fatty Liver at Lower Body Weights Than Rural Peers

By Esther Okello / Oct 20, 2026

Urban Indians develop fatty liver at lower body weights than rural peers. Explore the lean liver paradox, why BMI misleads, and practical steps for diagnosis and care.

Atrial Fibrillation Screening in Rural Kerala Finds Strokes It Cannot Prevent

By Raphael Andriamanjato / Oct 20, 2026

Mobile ECG camps in rural Kerala are finding atrial fibrillation in people who cannot access the anticoagulation that would make detection worthwhile.

Ghana Weighs Herbal Sedatives Against Diazepam for Anxiety Care

By Esther Okello / Oct 20, 2026

Ghana's Mampong herbal clinic treats thousands for anxiety, but without published trial data, clinicians debate whether herbal sedatives can replace diazepam.

Glasgow's Diabetes Divide Starts in the Liver

By Raphael Andriamanjato / Oct 20, 2026

Type 2 diabetes and fatty liver follow Glasgow's wealth gradient. The biology of insulin resistance explains why the same condition damages livers unevenly.

In Brazil's Northeast, Hypertension Diagnoses Arrive After the Stroke

By Elena Vargas / Oct 20, 2026

In Brazil's Northeast, hypertension often goes unnoticed until a stroke brings patients to emergency wards. Surveys and clinicians describe a preventable cascade.

Kenya's Mental Health Fund Leaves Community Clinics Off the Reimbursement List

By Raphael Andriamanjato / Oct 20, 2026

Kenya's Mental Health Fund reimburses only accredited facilities, leaving community clinics and their patients to pay out of pocket for depression and anxiety care.

Malaria in Infants Treated Late at Both Ends of the Income Scale

By Raphael Andriamanjato / Oct 20, 2026

Malaria in infants is a race against the parasite's multiplication. Wealth doesn't always buy speed, and poverty adds hours that cost lives. A mechanism explainer.

Community Health Workers Catch Newborn Sepsis in Malawi Where Labs Cannot

By Min Park / Oct 20, 2026

In Malawi, community health workers use simple checklists to spot newborn sepsis where blood cultures are rare. Evidence shows promise, but referral delays and stockouts limit impact.

Ugandan Newborns Die of Sepsis While First-Line Antibiotics Miss the Organism

By Raphael Andriamanjato / Oct 20, 2026

In Uganda, WHO first-line antibiotics often fail against the bacteria causing neonatal sepsis. Clinicians and researchers disagree on whether to change empiric therapy.

Depression Treatment Guidelines Stall at Nigeria's Primary Care Gate

By Elena Vargas / Oct 20, 2026

Nigeria's depression guidelines rarely reach primary clinics. Payer rules, out-of-pocket costs and thin supervision keep treatment stuck at the gate.

Why Hospitals Keep Treating Resistant Infections With Older Drugs

By Raphael Andriamanjato / Oct 20, 2026

Older antibiotics like colistin and fosfomycin are back in wards facing resistant infections. Experts disagree on dosing, combinations, and how much kidney harm is acceptable.

Drug-Resistant Tuberculosis Care Splits Between Cape Town and Its Townships

By Elena Vargas / Oct 20, 2026

Cape Town's drug-resistant TB burden exposes stark contrasts in care between wealthy suburbs and townships, where delays, stockouts, and stigma undermine outcomes.

Depression Screening Scores Higher Than the Treatment It Refers To

By Esther Okello / Oct 20, 2026

Depression screening tools like the PHQ-9 are fast, validated and widely mandated. The referral pathways they feed into are slower, narrower and rarely measured.

Neonatal Jaundice Blocks Breastfeeding in Villages More Than in Cities

By Esther Okello / Oct 20, 2026

Neonatal jaundice is common everywhere, but rural newborns miss the bilirubin peak because discharge, follow-up and phototherapy all sit further away.

Asthma Guidelines Diverge on Rescue Inhaler Reliance Across Europe

By Elena Vargas / Oct 20, 2026

European asthma guidelines disagree on whether frequent rescue inhaler use is a warning sign or a rational habit, and the trial evidence behind each position is thinner than it looks.